Bone and Joint Infection
Conditions
Keywords
bone and joint infection, tedizolid, suppressive antibiotic therapy
Brief summary
the aim of the study is to describe the management and outcome of patients having an osteo-articular infection treated by tedizolid as a suppressive antibiotic therapy.
Interventions
OTHERpatients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic therapy
description of osteo-articular infection managed with tedizolid as a suppressive antibiotic therapy
Sponsors
Hospices Civils de Lyon
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Inclusion criteria
* patients having an osteo-articular infection treated with tedizolid as a suppressive antibiotic therapy
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| rate of patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic therapy | between 2016 and 2021 | proportion of patients having tedizolid as a suppressive antibiotic therapy |
| rate of failure in patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic | 2 years | proportion of patients having a failure under tedizolid as a suppressive antibiotic therapy |
| rate of adverse event in patients having had a BJI/PJI treated with tedizolid as a suppressive | through study completion, an average of 1 year | proportion of patients having a adverse event under tedizolid as a suppressive antibiotic therapy |
| Description of patients having had a BJI/PJI treated with tedizolid as a suppressive | 2 years | type of patients: age, CMI, comorbidities... |
| Description of BJI/PJI treated with tedizolid as a suppressive | 2 years | implant or prothese or not, acute/ chronic, bacteriology |
Countries
France
Outcome results
None listed